Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: Modulation by tacrolimus

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 226-237

  Morelli, Adrian E ^a   Antonysamy, Mary A ^a   Takayama, Takuya ^a   Hackstein, Holger ^a   Chen, Zongyou ^a   Qian, Shiguang ^a   Zurowski, Nancy B ^a   Thomson, Angus W ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; FLT3 LIGAND; GAMMA INTERFERON; HEMOPOIETIC GROWTH FACTOR; TACROLIMUS;

ALLOIMMUNITY; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; GRAFT SURVIVAL; HEMATOPOIETIC CELL; IMMUNOMODULATION; MALE; MICROCHIMERISM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034234596     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.226     Document Type: Article

References (61)

1. Starzl, T. E., A. J. Demetris, N. Murase, S. Ildstad, C. Ricordi, and M. Trucco. 1992. Cell migration, chimerism and graft acceptance. Lancet 339:1579.
2. Starzl, T. E., A. J. Demetris, N. Murase, M. Trucco, A. W. Thomson, and A. S. Rao. 1996. The lost chord: microchimerism and allograft survival. Immunol. Today 17:577.
3. Wood, K., and D. H. Sachs. 1995. Chimerism and transplant tolerance: cause and effect. Immunol. Today 17:584.
4. Bonham, C. A., L. Lu, and A. W. Thomson. 1997. Is chimerism necessary for tolerance and how? Curr. Opin. Organ Transplant. 2:23.
5. Sun, J., G. W. McCaughan, N. Gallagher, A. G. R. Sheil, and G. A. Bishop. 1995. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 60:233.
6. Tu, Y., T. Arima, and W. Flye. 1997. Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation. Transplantation 63:177.
7. Billingham, R. E., L. Brent, and P. B. Medawar. 1953. "Actively acquired tolerance" of foreign cells. Nature 172:603.
8. Billingham, R., L. Brent, and P. B. Medawar. 1956. Quantitative studies on tissue transplantation immunity. III. Actively acquired tolerance. Philos. Trans. R. Soc. London (B) 239:357.
9. Wood, M. L., A. P. Monaco, J. J. Gozzo, and A. Liegeois. 1971. Use of homozygous allogeneic bone marrow for induction of tolerance with anti-lymphocyte serum: dose and timing. Transplant. Proc. 3:676.
10. Wood, M. L., and A. P. Monaco. 1977. The effect of timing of skin grafts on subsequent survival in ALS-treated, marrow-infused mice. Transplantation 23: 78.
11. Thomas, J., M. Carver, B. Foil, C. Haisch, and F. Thomas. 1983. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 36:104.
12. Ildstad, S. T., and D. H. Sachs. 1984. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168.
13. Murase, N., T. E. Starzl, M. Tanabe, S. Fujisaki, H. Miyazawa, Q. Ye, C. P. Delaney, J. J. Fung, and A. J. Demetris, 1995. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats. Transplantation 60:158.
14. Barber, W. H., A. G. Diethelm, D. A. Laskow, M. H. Deierhoi, B. A. Julian, and J. J. Curtis. 1989. Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients. Transplantation 47:66.
15. McDaniel, D. O., J. Naftilan, K. Hulvey, S. Shaneyfelt, J. A. Lemons, S. Lagoo-Deenadayalan, S. Hudson, A. G. Diethelm, and W. H. Barber. 1994. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow. Transplantation 57:852.
16. Fontes, P., A. S. Rao, A. J. Demetris, A. Zeevi, M. Trucco, P. Carroll, W. Rybka, W. A. Rudert, C. Ricordi, F. Dodson, et al. 1994. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet 344:151.
17. Garcia-Morales, R., V. Esquenazi, K. Zucker, C. I. Gomez, L. Fuller, M. Carreno, R. Cirocco, A. Alamo, T. Karatzas, G. W. Burke III, et al. 1996. An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry. Transplantation 62:1149.
18. Lyman, S. D., L. James, T. Vanden Bos, P. de Vries, X. Brasel, B. Gliniak, L. T. Hollingsworth, K. S. Picha, H. J. McKenna, R. R. Splett, et al. 1993. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell 75:1157.
19. Hannum, C., J. Culpepper, D. Campbell, T. McClanahan, S. Zurawski, J. F. Bazan, R. Kastelein, S. Hudak, J. Wagner, J. Mattson, et al. 1994. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of hematopoietic stem cells and is encoded by variant RNAs. Nature 368:643.
20. Matthews, W., C. T. Jordan, G. W. Wiegand, D. Pardoll, and I. R. Lemischka. 1991. A receptor tyrosine kinase specific to hematopoietic stem and progenitor enriched populations. Cell 65:1143.
21. Rosnet, O., C. Schiff, M-J. Pebusque, S. Marchetto, C. Tonnelle, Y. Tolron, F. Birg, and D. Birnbaum. 1993. Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. Blood 82:1110.
22. Maraskovsky, E., K. Brasel, M. Teepe, E. R. Roux, S. D. Lyman, K. Shortman, and H. J. McKenna. 1996. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184:1953.
23. Drakes, M. L., L. Lu, V. M. Subbotin, and A. W. Thomson. 1997. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver. J. Immunol. 159:4268.
24. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
25. Bell, D., J. W. Young, and J. Banchereau. 1999. Dendritic cells. Adv. Immunol. 72:255.
26. Thomson, A. W., and L. Lu. 1999. Dendritic cells as regulators of immune reactivity: implications for transplantation. Transplantation 68:1.
27. Steptoe, R. J., F. Fu, W. Li, M. L. Drakes, L. Lu, A, J. Demetris, S. Qian, H. J. McKenna, and A. W. Thomson. 1997. Augmentation of dendritic cells in murine organ donors by flt3 ligand alters the balance between transplant tolerance and immunity. J. Immunol. 159:5483.
28. Lynch, D. H., A. Andreasen, E. Maraskovsky, J. Whitmore, R. E. Miller, and J. C. Schuh. 1997. Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat. Med. 3:625.
29. Pulendran, B., J. L. Smith, M. Jenkins, M. Schoenborn, E. Maraskovsky, and C. R. Maliszewski. 1998. Prevention of peripheral tolerance by a dendritic cell growth factor: Flt3 ligand as an adjuvant. J. Exp. Med. 188:2075.
30. Viney, J. L., A. M. Mowat, J. M. O'Malley, E. Williamson, and N. A. Fanger. 1998. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160:5815.
31. Iyengar, A. R., C. A. Bonham, M. A. Antonysamy, V. M. Subbotin, A. Khanna, N. Murase, A. S. Rao, T. E. Starzl, and A. W. Thomson. 1997. Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by flt3 ligand and tacrolimus. Transplantation 63:1193.
32. Antonysamy, M. A., R. J. Steptoe, A. Khanna, W. A. Rudert, V. M. Subbotin, and A. W. Thomson. 1998. Flt-3 L promotes microchimerism but can augment anti-donor immunity, J. Immunol. 160:4106.
33. dim, B7-2) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539.
34. dim, CD86) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 62:659.
35. Hayamizu, K., P. Huie, R. K. Sibley, and S. Strober. 1998. Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation. Transplantation 66:1285.
36. Suri, R. M., M. Niimi, K. J. Wood, and J. M. Austyn. 1998. Immature dendritic cell pretreatment induces cardiac allograft prolongation. J. Leukocyte Biol. 32(Suppl. 2):B16.
37. Rastellini, C., L. Lu, C. Ricordi, T. E. Starzl, A. S. Rao, and A. W. Thomson. 1995. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60:1366.
38. Gozzo, J., S. Masli, and S. De Fazio. 1999. Extension of graft survival with pulsed administration of donor dendritic cells. Transplant. Proc. 31:1196.
39. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 173:1693.
40. Antonysamy, M. A., W. C. Fanslow, F. Fu, W. Li, S. Qian, A. B. Troutt, and A. W. Thomson. 1999. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J. Immunol. 162:577.
41. Shaw, S.G., A. A. Maung, R. J. Steptoe, A. W. Thomson, and N. L. Vujanovic. 1998. Expansion of functional natural killer cells in multiple tissue compartments of mice treated with flt3-ligand: implications for anti-cancer and anti-viral therapy. J. Immunol 161:2817.
42. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356:607.
43. Lappin, M. B., J. M. Weiss, V. Delattre, B. Mai, H. Dittmar, C. Maier, K. Manke, S. Grabbe, S. Martin, and J. C. Simon. 1999. Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection. Immunology 98: 181.
44. Starzl, T. E., A. J. Demetris, M. Trucco, N. Murase, C. Ricordi, S. Ildstad, H. Ramos, S. Todo, A. Tzakis, J. J. Fung, et al. 1993. Cell migration and chimerism after whole-organ transplantation. Hepatology 17:1127.
45. Shapiro, R., A. S. Rao, P. Fontes, A. Zeevi, M. Jordan, V. P. Scantlebury, C. Vivas, H. A. Gritsch, R. J. Corry, F. Egidi. et al. 1995. Combined simultaneous kidney/bone marrow transplantation. Transplantation 60:1421.
46. Garcia-Morales, R., M. Carreno, J. Mathew, R. Cirocco, K. Zucker, G. Ciancio, G. Burke, D. Roth, D. Temple, L. Fuller, et al. 1998. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Transplantation 65:956.
47. Negrin, R. S. 1998. Clinical applications of hematopoietic growth factors. In The Cytokine Handbook, 3rd Ed. A. W. Thomson, ed. Academic Press, San Diego, p. 803.
48. Monaco, A. P., M. L. Wood, R. Gottschalk, and F. R. Seiler. 1991. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells. Transplantation 51:213.
49. Blazar, B. R., M. D. Widmer, C. C. B. Soderling, D. L. Urdal, S. Gillis, L. L. Robison, and D. A. Vallera. 1988. Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by GM-CSF. Blood 71:320.
50. Brasel, K., H. J. McKenna, P. J. Morrissey, K. Charrier, A. E. Morris, C. C. Lee, D. E. Williams, and S. D. Lyman. 1996. Hematologic effects of flt3 ligand in vivo in mice. Blood 88:2004.
51. Neipp, M., T. Zorina, M. A. Domenick, B. G. Exner, and S. T. Ilstad. 1998. Effect of flt3 ligand and granulocyte colony-stimulating factor on expansion and mobilization of facilitating cells and hematopoietic stem cells in mice: kinetics and repopulating potential. Blood 92:1177.
52. Terakura, M., N. Murase, A. J. Demetris, Q. Ye, A. W. Thomson, and T. E. Starzl. 1998. Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. Transplantation 66:350.
53. Linsley, P. S., and J. A. Ledbetter. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191.
54. Thompson, C. B. 1995. Distinct roles of the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979.
55. Lu, L., S. Qian, P. A. Hershberger, W. A. Rudert, D. H. Lynch, and A. W. Thomson. 1997. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J. Immunol. 158:5676.
56. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. V. Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263.
57. McLellan, A. D., R. V. Sorg, L. A. Williams, and D. N. J. Hart. 1996. Human dendritic cells activate T lymphocytes via a CD40-CD40 ligand-dependent pathway. Eur. J. Immunol. 26:1204.
58. Koch, F., U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, and G. Schuler. 1996. High levels of IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:741.
59. Lu, L., W. Li, F. Fu, F. G. Chambers, S. Qian, J. J. Fung, and A. W. Thomson. 1997. Blockade of the CD40-CD40L pathway potentiates the capacity of donor-derived DC progenitors to induce long-term cardiac allograft survival. Transplantation 64:1808.
60. Markees, T. G., N. E. Phillips, E. J. Gordon, R. J. Noelle, C. Maliszewski, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 1999. Prolonged skin allograft survival in mice treated with flt3-ligand-induced dendritic cells and anti-CD 154 monoclonal antibody. Transplant. Proc. 31:884.
61. Pearson, T. C., D. Z. Alexander, R. Hendrix, E. T. Elwood, P. S. Linsley, K. J. Winn, and C. P. Larsen. 1996. CTLA41g plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model. Transplantation 61:997.